1
|
Rowe S, Janssens K, Mitchell A, D'Ambrosio P, De Paepe J, Van Soest S, Calvo-Lopez M, Cullen O, Spencer L, Dausin C, Ghekiere O, Bogaert J, Herbots L, Bekhuis Y, Pauwels R, Willems R, Heidbuchel H, Claessen G, La Gerche A. Female endurance athletes: smaller hearts but similar relationship between ventricular size, fitness and fibrosis as male athletes. Br J Sports Med 2025:bjsports-2024-109503. [PMID: 40306764 DOI: 10.1136/bjsports-2024-109503] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/20/2025] [Indexed: 05/02/2025]
Abstract
OBJECTIVES Exercise-induced cardiac remodelling is well described in male athletes but incompletely understood in females. This study aimed to examine sex differences in cardiac structure, function and fibrosis relative to fitness and to determine reference ranges for 'normal' chamber size in a large cohort of healthy male and female highly trained endurance athletes. METHODS This multicentre international study used cardiac MRI and cardiopulmonary exercise testing (VO2peak) to assess sex-specific relationships between measures of biventricular chamber size, function, fibrosis and VO2peak. RESULTS Of the 364 endurance athletes included, 36.5% were female. Compared with males, female athletes achieved lower VO2peak (51 (40-57) vs 59 (41-65) mL/kg/min, p<0.001), had smaller absolute and body surface area (BSA)-indexed left and right end-diastolic volumes (LVEDV, respectively) but similar volumes when indexed to fat-free mass. Both sexes showed a strong association between LVEDV and VO2peak (r=0.60-0.66) and a similar coefficient describing the linear relationship between VO2peak and LVEDV (Females: VO2peak(mL/min)=12.1×LVEDV+963.9; males: VO2peak=15.3×LVEDV+806.8, p=0.100) and BSA-indexed LVEDV (females: VO2peak (mL/kg/min)=0.37×LVEDV/BSA+12.5; males: VO2peak=0.51×LVEDV/BSA-1.2, p=0.059). There was no difference between right ventricular (RV) measures and VO2peak; however, males had 3.8 times higher odds of reduced RV ejection fraction. Prevalent myocardial scar was similar for both female (14.2%) and male (19.9%) athletes (p=0.180). CONCLUSIONS Female and male athletes demonstrate similar cardiac remodelling relative to fitness and no sex difference in myocardial scar. The female athlete's heart can show profound adaptation, and previous assertions that female hearts have lesser capacity for remodelling should be reappraised.
Collapse
Affiliation(s)
- Stephanie Rowe
- Heart, Exercise and Research Trials, St Vincent's Institute of Medical Research, Melbourne, Victoria, Australia
- Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia
- St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia
| | - Kristel Janssens
- Heart, Exercise and Research Trials, St Vincent's Institute of Medical Research, Melbourne, Victoria, Australia
- Exercise and Nutrition Research Program, Australian Catholic University Mary MacKillop Institute for Health Research, Melbourne, Victoria, Australia
| | - Amy Mitchell
- Heart, Exercise and Research Trials, St Vincent's Institute of Medical Research, Melbourne, Victoria, Australia
| | - Paolo D'Ambrosio
- Heart, Exercise and Research Trials, St Vincent's Institute of Medical Research, Melbourne, Victoria, Australia
- Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia
| | - Jarne De Paepe
- Department of Cardiovascular Sciences, UZ Leuven, Leuven, Belgium
- Department of Cardiovascular Diseases, KU Leuven, Leuven, Belgium
- Faculty of Medicine and Life Sciences/LCRC, UHasselt, Hasselt, Belgium
| | - Sofie Van Soest
- Department of Cardiovascular Sciences, UZ Leuven, Leuven, Belgium
| | - Margarita Calvo-Lopez
- Heart, Exercise and Research Trials, St Vincent's Institute of Medical Research, Melbourne, Victoria, Australia
- Department of Cardiology, Clinic Hospital, Barcelona, Spain
| | - Oscar Cullen
- Heart, Exercise and Research Trials, St Vincent's Institute of Medical Research, Melbourne, Victoria, Australia
| | - Luke Spencer
- Heart, Exercise and Research Trials, St Vincent's Institute of Medical Research, Melbourne, Victoria, Australia
- Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia
| | | | - Olivier Ghekiere
- Faculty of Medicine and Life Sciences/LCRC, UHasselt, Hasselt, Belgium
- Radiology, Jessa Hospital, Hasselt, Belgium
| | - Jan Bogaert
- Department of Radiology, University Hospital Gasthuisberg, Leuven, Belgium
- Department of Imaging and Pathology, KU Leuven, Leuven, Belgium
| | - Lieven Herbots
- Faculty of Medicine and Life Sciences/LCRC, UHasselt, Hasselt, Belgium
- Hartcentrum Hasselt, Hasselt, Belgium
| | - Youri Bekhuis
- Department of Cardiovascular Sciences, UZ Leuven, Leuven, Belgium
- Department of Cardiovascular Diseases, KU Leuven, Leuven, Belgium
- Faculty of Medicine and Life Sciences/LCRC, UHasselt, Hasselt, Belgium
- Hartcentrum Hasselt, Hasselt, Belgium
| | - Rik Pauwels
- Department of Cardiovascular Sciences, UZ Leuven, Leuven, Belgium
- Department of Cardiovascular Diseases, KU Leuven, Leuven, Belgium
- Faculty of Medicine and Life Sciences/LCRC, UHasselt, Hasselt, Belgium
- Hartcentrum Hasselt, Hasselt, Belgium
| | - Rik Willems
- Department of Cardiovascular Sciences, UZ Leuven, Leuven, Belgium
- Department of Cardiovascular Diseases, KU Leuven, Leuven, Belgium
| | - Hein Heidbuchel
- Department of Cardiovascular Sciences, University of Antwerp, Antwerpen, Belgium
- Department of Cardiology, University Hospital, Edegem, Belgium
| | - Guido Claessen
- Department of Cardiovascular Diseases, KU Leuven, Leuven, Belgium
- Faculty of Medicine and Life Sciences/LCRC, UHasselt, Hasselt, Belgium
- Hartcentrum Hasselt, Hasselt, Belgium
| | - André La Gerche
- Heart, Exercise and Research Trials, St Vincent's Institute of Medical Research, Melbourne, Victoria, Australia
- St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia
- Victor Chang Cardiac Research Institute, Darlinghurst, New South Wales, Australia
| |
Collapse
|
2
|
Morita H, Asada S, Nagase S, Ueoka A, Masuda T, Miyamoto M, Nakagawa K, Nishii N, Yuasa S. Late gadolinium enhancement in early repolarization syndrome. Heart Rhythm 2025; 22:767-775. [PMID: 39094725 DOI: 10.1016/j.hrthm.2024.07.116] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/27/2023] [Revised: 07/15/2024] [Accepted: 07/27/2024] [Indexed: 08/04/2024]
Abstract
BACKGROUND In patients with Brugada syndrome, myocardial fibrosis can be identified through epicardial biopsy or cardiac magnetic resonance (CMR) imaging with late gadolinium enhancement (LGE). However, the myocardial alterations in patients with early repolarization syndrome (ERS) remain poorly elucidated. OBJECTIVE The objective of this study was to investigate the presence of myocardial fibrosis in patients with ERS by LGE in CMR. METHODS We retrospectively evaluated 20 patients with ERS, all of whom exhibited J waves in the contiguous 2 leads. The location of J waves was classified as in the septum (V1-V2), anterior (V3-V4), lateral (I, aVL, V5-V6), inferior (II, III, aVF), or posterior (V7-V9) regions. To compare the distribution of LGE on CMR imaging with J waves, sections on short-axis view of the left ventricle (LV) were categorized as located in the septum, anterior, lateral, inferior, and posterior regions. RESULTS Overall, 85% of ERS patients displayed LGE, which was more prevalent in the septum and posterior regions, followed by the inferior and lateral regions. The presence or absence of J waves and LGE coincided in 61% of LV areas, whereas discordance between the distributions of J waves and LGE was observed in 38%. LGE was most frequent in the septum (75%), where its reflection in J waves may be less robust. The appearance of LGE was not associated with symptoms, electrical storm, or ventricular fibrillation occurrence during follow-up. CONCLUSION LGE is common in patients with ERS, and the distribution of J waves and LGE coincides in approximately 60% of LV areas.
Collapse
Affiliation(s)
- Hiroshi Morita
- Department of Cardiovascular Therapeutics, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
| | - Saori Asada
- Department of Cardiovascular Medicine, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan
| | - Satoshi Nagase
- Department of Advanced Arrhythmia and Translational Medical Science, National Cerebral and Cardiovascular Center, Suita, Japan; Department of Cardiovascular Medicine, Kawasaki Medical School General Medical Center, Okayama, Japan
| | - Akira Ueoka
- Department of Cardiovascular Medicine, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan
| | - Takuro Masuda
- Department of Cardiovascular Medicine, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan
| | - Masakazu Miyamoto
- Department of Cardiovascular Medicine, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan
| | - Koji Nakagawa
- Department of Cardiovascular Medicine, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan
| | - Nobuhiro Nishii
- Department of Cardiovascular Therapeutics, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
| | - Shinsuke Yuasa
- Department of Cardiovascular Medicine, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan
| |
Collapse
|
3
|
Androulakis E, Marwaha S, Dikaros N, Bhatia R, MacLachlan H, Fyazz S, Chatrath N, Merghani A, Finocchiaro G, Sharma S, Papadakis M. Non-specific myocardial fibrosis in young competitive athletes: clinical significance and risk prediction by a powerful machine learning-based model. Clin Res Cardiol 2024:10.1007/s00392-024-02550-y. [PMID: 39400567 DOI: 10.1007/s00392-024-02550-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/27/2024] [Accepted: 09/17/2024] [Indexed: 10/15/2024]
Abstract
BACKGROUND Non-specific myocardial fibrosis (NSMF) is a heterogeneous entity. We aimed to evaluate young athletes with and without NSMF to establish potentially clinically significance. METHODS We analysed data from 328 young athletes. We identified 61 with NSMF and compared them with 75 matched controls. Athletes with NSMF were divided into Group 1 (n = 28) with 'minor' fibrosis and Group 2 (n = 33) with non-insertion point fibrosis, defined as 'major'. Athletes were followed-up for adverse events. Finally, we tested various machine learning (ML) algorithms to create a prediction model for 'major' fibrosis. We created 4 different classifiers. RESULTS Athletes of black ethnicity were more likely to have a subepicardial pattern (OR: 5.0, p = 0.004). Athletes with 'major' fibrosis demonstrated a higher prevalence of lateral T-wave inversion (TWI) ( < 0.001) and ventricular arrhythmias (VEs > 500/24 h, p = 0.046; non-sustained VT, p = 0.043). Athletes with 'minor' fibrosis demonstrated higher right ventricular volumes (p = 0.013), maximum Watts (p = 0.022) and maximum VO2 (p = 0.005). Lateral TWI (p = 0.026) and VO2 < 44 mL/min/Kg (p = 0.040) remained the only significant predictors for 'major' fibrosis. During follow up, athletes with 'major' fibrosis were 9.1 times more likely to exhibit adverse events (OR 13.4, p = 0.041). All ML models outperformed the benchmark method in predicting significant MF, best accuracy achieved by the random forest classifier (90%). CONCLUSIONS Lateral TWI and reduced exercise performance are associated with higher burden of fibrosis. Fibrosis was associated with increased ventricular arrhythmia and adverse events. A comprehensive assessment can help develop a ML-based model for significant fibrosis, which could also guide clinical practice and appropriate CMR referrals.
Collapse
Affiliation(s)
| | - S Marwaha
- St George's University London, London, UK
| | - N Dikaros
- Hellenic Ministry of Interior, Administrative Reform and e-Governance, Athens, Greece
| | - R Bhatia
- St George's University London, London, UK
| | | | - S Fyazz
- St George's University London, London, UK
| | - N Chatrath
- St George's University London, London, UK
| | - A Merghani
- University Hospital of Northern British Columbia, Prince George, Canada
| | | | - S Sharma
- St George's University London, London, UK
| | | |
Collapse
|
4
|
Allwood RP, Papadakis M, Androulakis E. Myocardial Fibrosis in Young and Veteran Athletes: Evidence from a Systematic Review of the Current Literature. J Clin Med 2024; 13:4536. [PMID: 39124802 PMCID: PMC11313657 DOI: 10.3390/jcm13154536] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2024] [Revised: 07/29/2024] [Accepted: 07/30/2024] [Indexed: 08/12/2024] Open
Abstract
Background: Exercise is associated with several cardiac adaptations that can enhance one's cardiac output and allow one to sustain a higher level of oxygen demand for prolonged periods. However, adverse cardiac remodelling, such as myocardial fibrosis, has been identified in athletes engaging in long-term endurance exercise. Cardiac magnetic resonance (CMR) imaging is considered the noninvasive gold standard for its detection and quantification. This review seeks to highlight factors that contribute to the development of myocardial fibrosis in athletes and provide insights into the assessment and interpretation of myocardial fibrosis in athletes. Methods: A literature search was performed using the PubMed/Medline database and Google Scholar for publications that assessed myocardial fibrosis in athletes using CMR. Results: A total of 21 studies involving 1642 endurance athletes were included in the analysis, and myocardial fibrosis was found in 378 of 1595 athletes. A higher prevalence was seen in athletes with cardiac remodelling compared to control subjects (23.7 vs. 3.3%, p < 0.001). Similarly, we found that young endurance athletes had a significantly higher prevalence than veteran athletes (27.7 vs. 19.9%, p < 0.001), while male and female athletes were similar (19.7 vs. 16.4%, p = 0.207). Major myocardial fibrosis (nonischaemic and ischaemic patterns) was predominately observed in veteran athletes, particularly in males and infrequently in young athletes. The right ventricular insertion point was the most common fibrosis location, occurring in the majority of female (96%) and young athletes (84%). Myocardial native T1 values were significantly lower in athletes at 1.5 T (p < 0.001) and 3 T (p = 0.004), although they had similar extracellular volume values to those of control groups. Conclusions: The development of myocardial fibrosis in athletes appears to be a multifactorial process, with genetics, hormones, the exercise dose, and an adverse cardiovascular risk profile playing key roles. Major myocardial fibrosis is not a benign finding and warrants a comprehensive evaluation and follow-up regarding potential cardiac disease.
Collapse
Affiliation(s)
- Richard P. Allwood
- Sports Cardiology Department, Baker Heart and Diabetes Institute, Melbourne 3004, Australia
| | - Michael Papadakis
- Cardiovascular Clinical Academic Group, St George’s, University of London, London SW17 0RE, UK;
| | - Emmanuel Androulakis
- Cardiovascular Clinical Academic Group, St George’s, University of London, London SW17 0RE, UK;
| |
Collapse
|
5
|
Tsampasian V, Androulakis E, Catumbela R, Gati S, Papadakis M, Vassiliou VS. Prevalence of Abnormal Cardiovascular Magnetic Resonance Findings in Athletes Recovered from COVID-19 Infection: A Systematic Review and Meta-Analysis. J Clin Med 2024; 13:3290. [PMID: 38893000 PMCID: PMC11172781 DOI: 10.3390/jcm13113290] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2024] [Revised: 04/19/2024] [Accepted: 05/31/2024] [Indexed: 06/21/2024] Open
Abstract
Background: Competitive sports and high-level athletic training result in a constellation of changes in the myocardium that comprise the 'athlete's heart'. With the spread of the COVID-19 pandemic, there have been concerns whether elite athletes would be at higher risk of myocardial involvement after infection with the virus. This systematic review and meta-analysis evaluated the prevalence of abnormal cardiovascular magnetic resonance (CMR) findings in elite athletes recovered from COVID-19 infection. Methods: The PubMed, Cochrane and Web of Science databases were systematically search from inception to 15 November 2023. The primary endpoint was the prevalence of abnormal cardiovascular magnetic resonance findings, including the pathological presence of late gadolinium enhancement (LGE), abnormal T1 and T2 values and pericardial enhancement, in athletes who had recovered from COVID-19 infection. Results: Out of 3890 records, 18 studies with a total of 4446 athletes were included in the meta-analysis. The pooled prevalence of pathological LGE in athletes recovered from COVID-19 was 2.0% (95% CI 0.9% to 4.4%, I2 90%). The prevalence of elevated T1 and T2 values was 1.2% (95% CI 0.4% to 3.6%, I2 87%) and 1.2% (95% CI 0.4% to 3.7%, I2 89%), respectively, and the pooled prevalence of pericardial involvement post COVID-19 infection was 1.1% (95% CI 0.5% to 2.5%, I2 85%). The prevalence of all abnormal CMR findings was much higher among those who had a clinical indication of CMR. Conclusions: Among athletes who have recently recovered from COVID-19 infection, there is a low prevalence of abnormal CMR findings. However, the prevalence is much higher among athletes with symptoms and/or abnormal initial cardiac screening. Further studies and longer follow up are needed to evaluate the clinical relevance of these findings and to ascertain if they are associated with adverse events.
Collapse
Affiliation(s)
- Vasiliki Tsampasian
- Norwich Medical School, Faculty of Medicine and Health Sciences, University of East Anglia, Norwich NR4 7UG, UK
- Norfolk and Norwich University Hospital, Norwich NR4 7TJ, UK
| | - Emmanuel Androulakis
- Cardiovascular Clinical Academic Group, St. George’s University of London, London SW17 0RE, UK; (E.A.); (M.P.)
| | | | - Sabiha Gati
- School of Medicine, Imperial College London, London SW7 2BX, UK;
- Royal Brompton Hospital, London SW3 6NP, UK
| | - Michael Papadakis
- Cardiovascular Clinical Academic Group, St. George’s University of London, London SW17 0RE, UK; (E.A.); (M.P.)
| | - Vassilios S. Vassiliou
- Norwich Medical School, Faculty of Medicine and Health Sciences, University of East Anglia, Norwich NR4 7UG, UK
- Norfolk and Norwich University Hospital, Norwich NR4 7TJ, UK
| |
Collapse
|
6
|
Miljoen H, Favere K, Van De Heyning C, Corteville B, Dausin C, Herbots L, Teulingkx T, Bekhuis Y, Lyssens M, Bogaert J, Heidbuchel H, Claessen G. Low rates of myocardial fibrosis and ventricular arrhythmias in recreational athletes after SARS-CoV-2 infection. Front Cardiovasc Med 2024; 11:1372028. [PMID: 38628312 PMCID: PMC11018940 DOI: 10.3389/fcvm.2024.1372028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2024] [Accepted: 02/26/2024] [Indexed: 04/19/2024] Open
Abstract
Introduction High rates of cardiac involvement were reported in the beginning of the coronavirus disease 2019 (COVID-19) pandemic. This led to anxiety in the athletic population. The current study was set up to assess the prevalence of myocardial fibrosis and ventricular arrhythmias in recreational athletes with the recent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Methods Consecutive adult recreational athletes (≥18 years old, ≥4 h of mixed type or endurance sports/week) underwent systematic cardiac evaluation after a prior confirmed COVID-19 infection. Evaluation included clinical history, electrocardiogram (ECG), 5-day Holter monitoring, and cardiac magnetic resonance (CMR) imaging with simultaneous measurement of high-sensitive cardiac Troponin I. Data from asymptomatic or mildly symptomatic athletes (Group 1) were compared with those with moderate to severe symptoms (Groups 2-3). Furthermore, a comparison with a historical control group of athletes without COVID-19 (Master@Heart) was made. Results In total, 35 athletes (18 Group 1, 10 female, 36.9 ± 2.2 years, mean 143 ± 20 days following diagnosis) were evaluated. The baseline characteristics for the Group 1 and Groups 2-3 athletes were similar. None of the athletes showed overt myocarditis on CMR based on the updated Lake Louise criteria for diagnosis of myocarditis. The prevalence of non-ischemic late gadolinium enhancement [1 (6%) Group 1 vs. 2 (12%) Groups 2-3; p = 0.603] or ventricular arrhythmias [1 Group 1 athlete showed non-sustained ventricular tachycardia (vs. 0 in Groups 2-3: p = 1.000)] were not statistically different between the groups. When the male athletes were compared with the Master@Heart athletes, again no differences regarding these criteria were found. Conclusion In our series of recreational athletes with prior confirmed COVID-19, we found no evidence of ongoing myocarditis, and no more detection of fibrosis or ventricular arrhythmias than in a comparable athletic pre-COVID cohort. This points to a much lower cardiac involvement of COVID-19 in athletes than originally suggested.
Collapse
Affiliation(s)
- Hielko Miljoen
- Department of Cardiology, Antwerp University Hospital, Antwerp, Belgium
- Research Group Cardiovascular Diseases, Department GENCOR, University of Antwerp, Antwerp, Belgium
| | - Kasper Favere
- Department of Cardiology, Antwerp University Hospital, Antwerp, Belgium
- Research Group Cardiovascular Diseases, Department GENCOR, University of Antwerp, Antwerp, Belgium
- Department of Internal Medicine, Ghent University, Ghent, Belgium
| | - Caroline Van De Heyning
- Department of Cardiology, Antwerp University Hospital, Antwerp, Belgium
- Research Group Cardiovascular Diseases, Department GENCOR, University of Antwerp, Antwerp, Belgium
| | - Ben Corteville
- Department of Cardiology, Jan Palfijn Hospital, Ghent, Belgium
| | - Christophe Dausin
- Exercise Physiology Research Group, Department of Movement Sciences, KU Leuven, Leuven, Belgium
| | - Lieven Herbots
- Department of Cardiology, Hartcentrum, Jessa Hospital, Hasselt, Belgium
- Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium
| | | | - Youri Bekhuis
- Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium
- Department of Cardiology, Leuven University Hospitals, Leuven, Belgium
- Department of Cardiovascular Sciences, Faculty of Medicine, KU Leuven, Leuven, Belgium
| | - Malou Lyssens
- Exercise Physiology Research Group, Department of Movement Sciences, KU Leuven, Leuven, Belgium
| | - Jan Bogaert
- Department of Imaging and Pathology, KU Leuven, Leuven, Belgium
- Department of Radiology, University Hospitals Leuven, Leuven, Belgium
| | - Hein Heidbuchel
- Department of Cardiology, Antwerp University Hospital, Antwerp, Belgium
- Research Group Cardiovascular Diseases, Department GENCOR, University of Antwerp, Antwerp, Belgium
- Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium
| | - Guido Claessen
- Department of Cardiology, Hartcentrum, Jessa Hospital, Hasselt, Belgium
- Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium
| |
Collapse
|
7
|
Thompson PD, Eijsvogels TMH, Kim JH. Can the Heart Get an Overuse Sports Injury? NEJM EVIDENCE 2023; 2:EVIDra2200175. [PMID: 38320102 DOI: 10.1056/evidra2200175] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/08/2024]
Abstract
Can the Heart Get an Overuse Sports Injury?Recent studies suggest that vigorous endurance exercise increases markers of cardiomyocyte injury and that lifelong endurance exercise may increase myocardial scarring, coronary artery atherosclerosis, AF, and aortic dilatation. This review summarizes the evidence linking these conditions with physical exertion and an approach to their management.
Collapse
Affiliation(s)
- Paul D Thompson
- Hartford Hospital, Hartford, CT
- University of Connecticut, Farmington, CT
- Massachusetts General Hospital, Boston
| | - Thijs M H Eijsvogels
- Radboud Institute for Health Sciences, Department of Physiology, Nijmegen, the Netherlands
- Radboud University Medical Center, Nijmegen, the Netherlands
| | - Jonathan H Kim
- Emory University School of Medicine, Atlanta
- Emory Clinical Cardiovascular Research Institute, Atlanta
| |
Collapse
|
8
|
Stegmüller F, Dinter J, Ritzer B, Seth C, Stadler L, Esefeld K, Halle M. [Sports cardiology : Which sport can be recommended for heart diseases?]. Herz 2022; 47:564-574. [PMID: 36278977 PMCID: PMC9590382 DOI: 10.1007/s00059-022-05141-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/14/2022] [Indexed: 11/30/2022]
Abstract
Within cardiology the field of sports cardiology has gradually increased in importance over the past 10 years. This is mainly due to the fact that the spectrum of issues relating to physical training in prevention and secondary prevention has expanded beyond classical cardiovascular rehabilitation. This spectrum affects above all adolescents and young adults with a manifest cardiac disease who want to continue being physically active and, in some cases strive for leisure and competitive sports. In addition, the group of patients with cardiac diseases who are still striving for top athletic performance even in old age and are looking for advice is continuously growing. In these cases, it is a matter of recommending physical training as a therapy strategy but also to protect the cardiovascular system. Dedicated recommendations for physical training must therefore also take individual aspects into consideration. In addition, the recommendation for the clearance for competitive sports is addressed in ambitious leisure and competitive sports. Patients ask about sport and training recommendations with cardiovascular risk factors, such as arterial hypertension, pathologies of the coronary arteries in the sense of a malformed outlet of coronary arteries, muscle bridges or coronary heart disease, cardiomyopathies and myocarditis as well as arrhythmia and cardiac valvular defects. This article discusses these diseases with the corresponding sport cardiological specific aspects and recommendations for physical training and competitive sports are given for each case.
Collapse
Affiliation(s)
- Felix Stegmüller
- Präventive Sportmedizin und Sportkardiologie/EAPC, Klinikum rechts der Isar, Technische Universität München, München, Deutschland
| | - Jonas Dinter
- Präventive Sportmedizin und Sportkardiologie/EAPC, Klinikum rechts der Isar, Technische Universität München, München, Deutschland
| | - Barbara Ritzer
- Präventive Sportmedizin und Sportkardiologie/EAPC, Klinikum rechts der Isar, Technische Universität München, München, Deutschland
| | - Celina Seth
- Präventive Sportmedizin und Sportkardiologie/EAPC, Klinikum rechts der Isar, Technische Universität München, München, Deutschland
| | - Luis Stadler
- Präventive Sportmedizin und Sportkardiologie/EAPC, Klinikum rechts der Isar, Technische Universität München, München, Deutschland
| | - Katrin Esefeld
- Präventive Sportmedizin und Sportkardiologie/EAPC, Klinikum rechts der Isar, Technische Universität München, München, Deutschland
| | - Martin Halle
- Präventive Sportmedizin und Sportkardiologie/EAPC, Klinikum rechts der Isar, Technische Universität München, München, Deutschland.
- Klinikum rechts der Isar, Lehrstuhl für Präventive und Rehabilitative Sportmedizin, EAPC Centre for Sports Cardiology, Technische Universität München, Georg-Brauchle-Ring 56, 80992, München, Deutschland.
| |
Collapse
|
9
|
La Gerche A, Wasfy MM, Brosnan MJ, Claessen G, Fatkin D, Heidbuchel H, Baggish AL, Kovacic JC. The Athlete's Heart-Challenges and Controversies: JACC Focus Seminar 4/4. J Am Coll Cardiol 2022; 80:1346-1362. [PMID: 36075838 DOI: 10.1016/j.jacc.2022.07.014] [Citation(s) in RCA: 35] [Impact Index Per Article: 11.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/15/2022] [Revised: 07/18/2022] [Accepted: 07/21/2022] [Indexed: 12/11/2022]
Abstract
Regular exercise promotes structural, functional, and electrical remodeling of the heart, often referred to as the "athlete's heart," with intense endurance sports being associated with the greatest degree of cardiac remodeling. However, the extremes of exercise-induced cardiac remodeling are potentially associated with uncommon side effects. Atrial fibrillation is more common among endurance athletes and there is speculation that other arrhythmias may also be more prevalent. It is yet to be determined whether this arrhythmic susceptibility is a result of extreme exercise remodeling, genetic predisposition, or other factors. Gender may have the greatest influence on the cardiac response to exercise, but there has been far too little research directed at understanding differences in the sportsman's vs sportswoman's heart. Here in part 4 of a 4-part seminar series, the controversies and ambiguities regarding the athlete's heart, and in particular, its arrhythmic predisposition, genetic, and gender influences are reviewed in depth.
Collapse
Affiliation(s)
- Andre La Gerche
- Clinical Research Domain, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia; National Centre for Sports Cardiology, Fitzroy, Victoria, Australia; Cardiology Department, St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia.
| | - Meagan M Wasfy
- Division of Cardiology, Massachusetts General Hospital, Boston, Massachusetts, USA; Cardiovascular Performance Program, Massachusetts General Hospital, Boston, Massachusetts, USA
| | - Maria J Brosnan
- National Centre for Sports Cardiology, Fitzroy, Victoria, Australia; Cardiology Department, St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia
| | - Guido Claessen
- Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium; Department of Cardiovascular Diseases, University Hospitals Leuven, Leuven, Belgium
| | - Diane Fatkin
- Victor Chang Cardiac Research Institute, Darlinghurst, New South Wales, Australia; School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Kensington, New South Wales, Australia; Cardiology Department, St Vincent's Hospital, Darlinghurst, New South Wales, Australia
| | - Hein Heidbuchel
- Antwerp University Hospital, Department of Cardiology, Antwerp, Belgium; Cardiovascular Sciences, Antwerp University, Antwerp, Belgium
| | - Aaron L Baggish
- Division of Cardiology, Massachusetts General Hospital, Boston, Massachusetts, USA; Cardiovascular Performance Program, Massachusetts General Hospital, Boston, Massachusetts, USA
| | - Jason C Kovacic
- Victor Chang Cardiac Research Institute, Darlinghurst, New South Wales, Australia; School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Kensington, New South Wales, Australia; Cardiology Department, St Vincent's Hospital, Darlinghurst, New South Wales, Australia; Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
| |
Collapse
|
10
|
Ricci F, Aquaro GD, De Innocentiis C, Rossi S, Mantini C, Longo F, Khanji MY, Gallina S, Pingitore A. Exercise-induced myocardial edema in master triathletes: Insights from cardiovascular magnetic resonance imaging. Front Cardiovasc Med 2022; 9:908619. [PMID: 35983187 PMCID: PMC9378862 DOI: 10.3389/fcvm.2022.908619] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2022] [Accepted: 07/05/2022] [Indexed: 11/17/2022] Open
Abstract
Background Strenuous exercise has been associated with functional and structural cardiac changes due to local and systemic inflammatory responses, reflecting oxidative, metabolic, hormonal, and thermal stress, even in healthy individuals. We aimed to assess changes in myocardial structure and function using cardiovascular magnetic resonance (CMR) imaging in master triathletes early after a full-distance Ironman Triathlon race. Materials and methods Ten master triathletes (age 45 ± 8 years) underwent CMR within 3 h after a full-distance Ironman Triathlon race (3.8 km swimming, 180 km cycling, and 42.2 km running) completed with a mean time of 12 ± 1 h. All the triathletes had a 30-day follow-up CMR. Cine balanced steady-state free precession, T2-short tau inversion recovery (STIR), tagging, and late gadolinium enhancement (LGE) imaging sequences were performed on a 1.5-T MR scanner. Myocardial edema was defined as a region with increased T2 signal intensity (SI) of at least two SDs above the mean of the normal myocardium. The extent of myocardial edema was expressed as the percentage of left ventricular (LV) mass. Analysis of LV strain and torsion by tissue tagging included the assessment of radial, longitudinal, and circumferential peak systolic strain, rotation, and twist. Results Compared with postrace, biventricular volumes, ejection fraction, and LV mass index remained unchanged at 30-day follow-up. Global T2 SI was significantly higher in the postrace CMR (postrace 10.5 ± 6% vs. follow-up 3.9 ± 3.8%, P = 0.004) and presented with a relative apical sparing distribution (P < 0.001) matched by reduction of radial peak systolic strain of basal segments (P = 0.003). Apical rotation and twist were significantly higher immediately after the competition compared with follow-up (P < 0.05). Conclusion Strenuous exercise in master triathletes is associated with a reversible regional increase in myocardial edema and reduction of radial peak systolic strain, both presenting with a relative apical sparing pattern.
Collapse
Affiliation(s)
- Fabrizio Ricci
- Department of Neuroscience, Imaging and Clinical Sciences, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
- Department of Clinical Sciences, Clinical Research Center, Lund University, Malmö, Sweden
- *Correspondence: Fabrizio Ricci,
| | | | - Carlo De Innocentiis
- Department of Neuroscience, Imaging and Clinical Sciences, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
| | - Serena Rossi
- Interventional Cath Lab, ASL 2 Abruzzo, Chieti, Italy
| | - Cesare Mantini
- Department of Neuroscience, Imaging and Clinical Sciences, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
| | | | - Mohammed Y. Khanji
- Newham University Hospital, Barts Health NHS Trust, London, United Kingdom
- William Harvey Research Institute, NIHR Barts Biomedical Research Centre, Queen Mary University of London, London, United Kingdom
- Barts Heart Centre, St Bartholomew’s Hospital, Barts Health NHS Trust, London, United Kingdom
| | - Sabina Gallina
- Department of Neuroscience, Imaging and Clinical Sciences, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
| | | |
Collapse
|
11
|
Moulson N, Gustus SK, Scirica C, Petek BJ, Vanatta C, Churchill TW, Guseh JS, Baggish A, Wasfy MM. Diagnostic evaluation and cardiopulmonary exercise test findings in young athletes with persistent symptoms following COVID-19. Br J Sports Med 2022; 56:bjsports-2021-105157. [PMID: 35584886 PMCID: PMC9157326 DOI: 10.1136/bjsports-2021-105157] [Citation(s) in RCA: 25] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/03/2022] [Indexed: 12/22/2022]
Abstract
OBJECTIVES Persistent or late-onset cardiopulmonary symptoms following COVID-19 may occur in athletes despite a benign initial course. We examined the yield of cardiac evaluation, including cardiopulmonary exercise testing (CPET), in athletes with cardiopulmonary symptoms after COVID-19, compared CPETs in these athletes and those without COVID-19 and evaluated longitudinal changes in CPET with improvement in symptoms. METHODS This prospective cohort study evaluated young (18-35 years old) athletes referred for cardiopulmonary symptoms that were present>28 days from COVID-19 diagnosis. CPET findings in post-COVID athletes were compared with a matched reference group of healthy athletes without COVID-19. Post-COVID athletes underwent repeat CPET between 3 and 6 months after initial evaluation. RESULTS Twenty-one consecutive post-COVID athletes with cardiopulmonary symptoms (21.9±3.9 years old, 43% female) were evaluated 3.0±2.1 months after diagnosis. No athlete had active inflammatory heart disease. CPET reproduced presenting symptoms in 86%. Compared with reference athletes (n=42), there was similar peak VO2 but a higher prevalence of abnormal spirometry (42%) and low breathing reserve (42%). Thirteen athletes (62%) completed longitudinal follow-up (4.8±1.9 months). The majority (69%) had reduction in cardiopulmonary symptoms, accompanied by improvement in peak VO2 and oxygen pulse, and reduction in resting and peak heart rate (all p<0.05). CONCLUSION Despite a high burden of cardiopulmonary symptoms after COVID-19, no athlete had active inflammatory heart disease. CPET was clinically useful to reproduce symptoms with either normal testing or identification of abnormal spirometry as a potential therapeutic target. Improvement in post-COVID symptoms was accompanied by improvements in CPET parameters.
Collapse
Affiliation(s)
- Nathaniel Moulson
- Cardiology Division, The University of British Columbia, Vancouver, British Columbia, Canada
| | - Sarah K Gustus
- Cardiovascular Performance Program, Massachusetts General Hospital, Boston, Massachusetts, USA
| | - Christina Scirica
- Pediatric Pulmonary Medicine Division, Massachusetts General Hospital, Boston, Massachusetts, USA
| | - Bradley J Petek
- Cardiovascular Performance Program, Massachusetts General Hospital, Boston, Massachusetts, USA
- Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts, USA
| | - Caroyln Vanatta
- Cardiovascular Performance Program, Massachusetts General Hospital, Boston, Massachusetts, USA
| | - Timothy W Churchill
- Cardiovascular Performance Program, Massachusetts General Hospital, Boston, Massachusetts, USA
- Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts, USA
| | - James Sawalla Guseh
- Cardiovascular Performance Program, Massachusetts General Hospital, Boston, Massachusetts, USA
- Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts, USA
| | - Aaron Baggish
- Cardiovascular Performance Program, Massachusetts General Hospital, Boston, Massachusetts, USA
- Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts, USA
| | - Meagan M Wasfy
- Cardiovascular Performance Program, Massachusetts General Hospital, Boston, Massachusetts, USA
- Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts, USA
| |
Collapse
|
12
|
Zorzi A, Cipriani A, Corrado D. COVID-19 viral infection and myocarditis in athletes: the need for caution in interpreting cardiac magnetic resonance findings. Br J Sports Med 2022; 56:999-1000. [PMID: 35393365 DOI: 10.1136/bjsports-2022-105470] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/20/2022] [Indexed: 12/12/2022]
Affiliation(s)
- Alessandro Zorzi
- Department of Cardiac, Thoracic, and Vascular Sciences and Public Health, Università degli Studi di Padova, Padova, Veneto, Italy
| | - Alberto Cipriani
- Department of Cardiac, Thoracic, and Vascular Sciences and Public Health, Università degli Studi di Padova, Padova, Veneto, Italy
| | - Domenico Corrado
- Department of Cardiac, Thoracic, and Vascular Sciences and Public Health, Università degli Studi di Padova, Padova, Veneto, Italy
| |
Collapse
|